PATENT CLAIM ANALYSIS

Application Number: 16144786
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "093700"]

Abstract:
The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition

Claim (Index 1):
A method for improving neural function in the central nervous system (CNS) of a mammal having impaired neural function, comprising:\n transplanting genetically-modified medial ganglionic eminence (MGE) precursor cells into the CNS of the mammal.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.60714
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14943916', '13744201', '14847686', '12161527', '14763397']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7662144649563732
- 35 USC 102 Novelty (BERT): 0.6455747959626286
- Combined Prediction Score: 0.7541504980569989
- Mean Citation Score: 462.8974099999999
- Max Citation Score: 623.3102
- Similarity Product: 596.04261531142

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test